For generations, countless home remedies — cups of warm tea or soups ... is fighting off a virus lodged in your upper airways. The swelling and pain can make it more difficult to swallow food ...

Tamarind seeds are gaining attention for their potential to alleviate arthritis pain due to their anti-inflammatory ...

Waking up with a puffy face can throw off your entire morning: Upon rolling out of bed and sulking to the bathroom, you peek at your reflection and are shocked by swelling around the eyes, cheeks, and ...

Intellia Therapeutics fell 20.5% the day after it reported Phase 2 test results for a promising treatment. Explore more ...

This review will focus on the determinants and treatment stratagems of peripheral edema in patients being treated with CCBs. This is a common clinical problem and often is a significant deterrent ...

Quantifying edema is difficult -- both for patient and physician -- and is generally reported on a four-point scale. Because of the subjective nature of this scale, the location of the edema ...

The Global Edema Clinical Trials Market is valued at approximately USD 877.31 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2024-2032 ...

They can show you safe exercises and other techniques to help you avoid or reduce swelling. Weight gain or loss You might have either during your treatment. Weight loss might be due to nausea ...

An aflibercept biosimilar is “clinically equivalent” to the reference drug when used in the treatment of diabetic macular edema (DME), according to trial results published in JAMA Ophthalmology.

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

“Vabysmo has been shown to be an effective first-line treatment for diabetic macular edema, and for the first time, we now have data demonstrating its ability to improve vision in ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...